Herjan相关文献与解析，生知库 | 链接生命科学的每一步

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males

前列腺癌患者因雄激素剥夺而导致的雌二醇水平下降，凸显了雌激素对男性的重要性。

Coelingh Bennink, Herjan J T; Prowse, Amanda; Egberts, Jan F M; Debruyne, Frans M J; Huhtaniemi, Ilpo T; Tombal, Bertrand

肿瘤

Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1

雌四醇抑制前列腺癌肿瘤刺激因子FSH和IGF-1

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm13195996

Coelingh Bennink, Herjan J T; Roos, Erik P M; van Moorselaar, R Jeroen A; van Melick, Harm H E; Somford, Diederik M; Roeleveld, Ton A; de Haan, Tjard D; Reisman, Yacov; Schultz, Iman J; Krijgh, Jan; Debruyne, Frans M J

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

排卵期月经周期中的孕酮是导致乳腺癌的重要因素。

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-023-01661-0

Coelingh Bennink, Herjan J T; Schultz, Iman J; Schmidt, Marcus; Jordan, V Craig; Briggs, Paula; Egberts, Jan F M; Gemzell-Danielsson, Kristina; Kiesel, Ludwig; Kluivers, Kirsten; Krijgh, Jan; Simoncini, Tommaso; Stanczyk, Frank Z; Langer, Robert D

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

一项多中心、随机、安慰剂对照研究，旨在确定绝经后女性雌四醇的最低有效剂量（E4Relief）：第二部分——阴道细胞学、绝经期泌尿生殖系统综合征和健康相关生活质量

期刊:Menopause-The Journal of the North American Menopause Society

影响因子:3

doi:10.1097/GME.0000000000002167

Gaspard, Ulysse; Taziaux, Mélanie; Jost, Maud; Coelingh Bennink, Herjan J T; Utian, Wulf H; Lobo, Rogerio A; Foidart, Jean-Michel

细胞生物学

发表日期：2023

文献求助收藏

A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen

肿瘤细胞特异性透明带糖蛋白3 RNA转录本编码一种细胞内癌抗原

期刊:Frontiers in Oncology

影响因子:

doi:10.3389/fonc.2023.1233039

Schultz, Iman J; Zimmerman, Yvette; Moelans, Cathy B; Chrusciel, Marcin; Krijgh, Jan; van Diest, Paul J; Huhtaniemi, Ilpo T; Coelingh Bennink, Herjan J T

IL-17-induced HIF1α drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion

IL-17 诱导的 HIF1α 通过成纤维细胞介导的免疫排斥驱动对抗 PD-L1 的耐药性

期刊:Journal of Experimental Medicine

影响因子:12.6

doi:10.1084/jem.20210693

Xing Chen #, Junjie Zhao #, Tomasz Herjan #, Lingzi Hong #, Yun Liao, Caini Liu, Kommireddy Vasu, Han Wang, Austin Thompson, Paul L Fox, Brian R Gastman, Xiao Li, Xiaoxia Li

Target expression is a relevant factor in synthetic lethal screens

靶标表达是合成致死筛选中的一个相关因素。

期刊:Communications Biology

影响因子:5.1

doi:10.1038/s42003-022-03746-6

Schultz, Iman J; Coelingh Bennink, Herjan J T

发表日期：2022

文献求助收藏

Premature ovarian insufficiency and the risk of breast cancer

卵巢早衰与乳腺癌风险

The rediscovery of estetrol and its implications for estrogen treatment

雌四醇的重新发现及其对雌激素治疗的意义

Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis

Act1 通过调节抗氧化 RNA 代谢和氧化还原稳态来驱动化学耐药性

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males

前列腺癌患者因雄激素剥夺而导致的雌二醇水平下降，凸显了雌激素对男性的重要性。

Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1

雌四醇抑制前列腺癌肿瘤刺激因子FSH和IGF-1

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer

排卵期月经周期中的孕酮是导致乳腺癌的重要因素。

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life

一项多中心、随机、安慰剂对照研究，旨在确定绝经后女性雌四醇的最低有效剂量（E4Relief）：第二部分——阴道细胞学、绝经期泌尿生殖系统综合征和健康相关生活质量

A tumor cell specific Zona Pellucida glycoprotein 3 RNA transcript encodes an intracellular cancer antigen

肿瘤细胞特异性透明带糖蛋白3 RNA转录本编码一种细胞内癌抗原

IL-17-induced HIF1α drives resistance to anti-PD-L1 via fibroblast-mediated immune exclusion

IL-17 诱导的 HIF1α 通过成纤维细胞介导的免疫排斥驱动对抗 PD-L1 的耐药性

Target expression is a relevant factor in synthetic lethal screens

靶标表达是合成致死筛选中的一个相关因素。